Keith Anthony Josephs

Keith Anthony Josephs's AcademicInfluence.com Rankings

Biology

#8041

World Rank

#11053

Historical Rank

Neuroscience

#1093

World Rank

#1135

Historical Rank

biology Degrees

Download Badge

Biology

Keith Anthony Josephs's Degrees

PhD Neuroscience University of California, San Francisco
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Keith Anthony Josephs Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Keith Anthony Josephs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS (2011) (4089)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. (2011) (3651)
Criteria for the diagnosis of corticobasal degeneration (2013) (1198)
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria (2017) (1150)
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. (2006) (602)
Pathological gambling caused by drugs used to treat Parkinson disease. (2005) (552)
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. (2006) (539)
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. (2004) (434)
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP (2006) (423)
An autoradiographic evaluation of AV-1451 Tau PET in dementia (2016) (383)
Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics (2012) (372)
Neuropathological background of phenotypical variability in frontotemporal dementia (2011) (368)
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease (2008) (343)
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (341)
Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study (2012) (336)
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease (2013) (311)
TDP-43 is a key player in the clinical features associated with Alzheimer’s disease (2014) (307)
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech (2012) (306)
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 (2011) (297)
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. (2007) (294)
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia (2008) (289)
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. (2005) (285)
Neuropathology of variants of progressive supranuclear palsy. (2010) (283)
Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) (2011) (267)
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. (2009) (263)
Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease (2015) (255)
When DLB, PD, and PSP masquerade as MSA (2015) (247)
Diagnostic Criteria for the Behavioral Variant of Frontotemporal Dementia (bvFTD): Current Limitations and Future Directions (2007) (246)
Neuropathology of non-motor features of Parkinson disease. (2009) (243)
Staging TDP-43 pathology in Alzheimer’s disease (2014) (238)
Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study (2013) (235)
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (230)
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative (2007) (218)
Updated TDP-43 in Alzheimer’s disease staging scheme (2016) (218)
β‐amyloid burden is not associated with rates of brain atrophy (2008) (216)
Voxel-based morphometry in autopsy proven PSP and CBD (2008) (214)
Corticobasal degeneration: a pathologically distinct 4R tauopathy (2011) (197)
Antemortem diagnosis of frontotemporal lobar degeneration (2005) (194)
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. (2018) (186)
Imaging correlates of posterior cortical atrophy (2007) (185)
Neurofilament inclusion body disease: a new proteinopathy? (2003) (180)
Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations (2007) (180)
Incidental Lewy body disease and preclinical Parkinson disease. (2008) (177)
Prominent phenotypic variability associated with mutations in Progranulin (2009) (176)
The Apraxia of Speech Rating Scale: a tool for diagnosis and description of apraxia of speech. (2014) (174)
Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage (2008) (168)
Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. (2008) (166)
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease (2008) (162)
Frontotemporal dementia and related disorders: Deciphering the enigma (2008) (162)
Frontotemporal lobar degeneration and ubiquitin immunohistochemistry (2004) (159)
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? (2017) (158)
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy (2015) (157)
Improved DTI registration allows voxel-based analysis that outperforms Tract-Based Spatial Statistics (2014) (157)
Cognitive impairment and celiac disease. (2006) (157)
Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. (2006) (156)
Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy (2008) (156)
Autoimmune dementia: clinical course and predictors of immunotherapy response. (2010) (155)
Globular glial tauopathies (GGT): consensus recommendations (2013) (155)
Rates of cerebral atrophy differ in different degenerative pathologies. (2006) (154)
Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. (2011) (151)
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases (2019) (146)
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology (2008) (146)
Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank (2003) (145)
High school football and risk of neurodegeneration: a community-based study. (2012) (143)
Quantitative application of the primary progressive aphasia consensus criteria (2014) (142)
Two distinct subtypes of right temporal variant frontotemporal dementia (2009) (136)
Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. (2005) (134)
TDP-43 in differential diagnosis of motor neuron disorders (2007) (133)
Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? (2011) (131)
Rapidly progressive neurodegenerative dementias. (2009) (130)
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease (2008) (129)
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia (2014) (127)
Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech (2015) (126)
Atypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration (2006) (125)
Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA (2013) (122)
[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy (2017) (116)
[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration (2016) (114)
Young-onset dementia: demographic and etiologic characteristics of 235 patients. (2008) (111)
Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts (2016) (110)
Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome (2005) (110)
Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. (2006) (109)
Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes (2009) (109)
Which ante mortem clinical features predict progressive supranuclear palsy pathology? (2017) (108)
Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis (2011) (108)
Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images (2015) (107)
Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer’s disease: a longitudinal retrospective study (2017) (107)
The evolution of primary progressive apraxia of speech. (2014) (106)
Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. (2010) (106)
Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART) (2017) (105)
Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome (2009) (105)
Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. (2011) (102)
FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type (2013) (102)
Neurophysiologic Studies in Morvan Syndrome (2004) (102)
Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. (2011) (101)
Sleep manifestations of voltage-gated potassium channel complex autoimmunity. (2011) (101)
Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72 (2015) (101)
Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration (2006) (97)
Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. (2011) (97)
Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND (2011) (97)
Capgras syndrome and its relationship to neurodegenerative disease. (2007) (95)
Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. (2006) (93)
Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. (2005) (93)
TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features (2015) (93)
Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers (2015) (93)
Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine (2005) (91)
Survival profiles of patients with frontotemporal dementia and motor neuron disease. (2009) (89)
Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. (2008) (89)
The anatomic correlate of prosopagnosia in semantic dementia (2008) (88)
MRI characteristics and scoring in HDLS due to CSF1R gene mutations (2012) (87)
The neuroanatomy of pure apraxia of speech in stroke (2014) (84)
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
IgLON5 antibody (2017) (83)
Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. (2007) (83)
Prosodic and phonetic subtypes of primary progressive apraxia of speech (2018) (82)
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers (2014) (82)
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease (2012) (81)
Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND (2005) (78)
Adult onset Niemann-Pick disease type C presenting with psychosis (2003) (77)
Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia (2015) (77)
Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations (2008) (74)
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy (2019) (74)
Review: Transactive response DNA‐binding protein 43 (TDP‐43): mechanisms of neurodegeneration (2010) (72)
Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy. (2007) (71)
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy (2019) (71)
Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration (2014) (71)
Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. (2004) (71)
18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies (2017) (71)
In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers (2017) (68)
Anatomical differences between CBS‐corticobasal degeneration and CBS‐Alzheimer's disease (2010) (68)
High School Football and Late‐Life Risk of Neurodegenerative Syndromes, 1956–1970 (2017) (67)
Argyrophilic grains: A distinct disease or an additive pathology? (2008) (67)
Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: An MRI and FDG-PET study (2013) (67)
Imaging Signatures of Molecular Pathology in Behavioral Variant Frontotemporal Dementia (2011) (67)
Visual hallucinations in posterior cortical atrophy. (2006) (67)
Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. (2004) (67)
TYROBP genetic variants in early-onset Alzheimer's disease (2016) (67)
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease (2018) (66)
The corticobasal syndrome–Alzheimer’s disease conundrum (2011) (66)
Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. (2006) (65)
Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology (2012) (64)
Progranulin-associated PiB-negative logopenic primary progressive aphasia (2014) (63)
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD (2019) (63)
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. (2020) (62)
Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (62)
Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes (2020) (61)
CHMP2B mutations are not a common cause of frontotemporal lobar degeneration (2006) (60)
Motor speech disorders associated with primary progressive aphasia (2014) (60)
The alien limb phenomenon (2013) (59)
A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. (2002) (59)
Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia (2012) (59)
Neuropsychological Profiles Differ among the Three Variants of Primary Progressive Aphasia (2015) (59)
FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis (2018) (58)
Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C (2016) (58)
Frontotemporal lobar degeneration without lobar atrophy. (2006) (57)
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology (2013) (57)
Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials. (2012) (57)
[18F]AV‐1451 tau‐PET and primary progressive aphasia (2018) (56)
Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates (2013) (56)
Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy? (2008) (55)
[18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease (2018) (55)
Symmetric corticobasal degeneration (S-CBD). (2010) (54)
Identification of an atypical variant of logopenic progressive aphasia (2013) (54)
Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: a prospective study. (2009) (54)
Clinical, FDG and amyloid PET imaging in posterior cortical atrophy (2015) (54)
FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants (2014) (54)
Primary progressive apraxia of speech: clinical features and acoustic and neurologic correlates. (2015) (53)
Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains (2019) (53)
Association of Apolipoprotein E &egr;4 With Transactive Response DNA-Binding Protein 43 (2018) (53)
Cerebellar ataxia and central nervous system whipple disease. (2005) (53)
Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions (2008) (53)
Psychogenic tremor: Long term prognosis in patients with electrophysiologically‐confirmed disease (2009) (53)
Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. (2013) (53)
Progressive supranuclear palsy: progression and survival (2016) (52)
The diagnosis and understanding of apraxia of speech: why including neurodegenerative etiologies may be important. (2012) (52)
Novel pathogenic mutations and copy number variations in the VPS13A Gene in patients with chorea‐acanthocytosis (2011) (52)
Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease (2008) (51)
Predicting future rates of tau accumulation on PET (2020) (50)
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia (2015) (50)
Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration (2007) (50)
Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease (2019) (49)
Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer’s disease presenting as logopenic progressive aphasia (2013) (49)
Predicting functional decline in behavioural variant frontotemporal dementia. (2011) (49)
Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults (2019) (49)
Frontotemporal Dementia Mimicking Dementia With Lewy Bodies (2008) (48)
Recent Advances in the Imaging of Frontotemporal Dementia (2012) (48)
MRI Correlates of Protein Deposition and Disease Severity in Postmortem Frontotemporal Lobar Degeneration (2009) (48)
Nonverbal oral apraxia in primary progressive aphasia and apraxia of speech (2014) (46)
Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau (2017) (45)
Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations (2011) (44)
Hippocampal Sclerosis and Ubiquitin-Positive Inclusions in Dementia Lacking Distinctive Histopathology (2004) (44)
Benign tremulous parkinsonism. (2006) (44)
Primary Progressive Aphasia and Apraxia of Speech (2013) (44)
Temporal acoustic measures distinguish primary progressive apraxia of speech from primary progressive aphasia (2017) (44)
Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype (2018) (42)
Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy (2017) (41)
Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease (2018) (41)
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy (2003) (41)
A novel tau mutation, p.K317N, causes globular glial tauopathy (2015) (41)
The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals (2019) (41)
Alien Hand Syndrome (2016) (40)
Gray matter correlates of behavioral severity in progressive supranuclear palsy (2011) (40)
Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. (2018) (40)
Minds on replay: musical hallucinations and their relationship to neurological disease. (2015) (40)
Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes. (2014) (40)
Anatomic correlates of stereotypies in frontotemporal lobar degeneration (2008) (40)
Nonvasculitic autoimmune inflammatory meningoencephalitis (2004) (40)
Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes. (2020) (39)
LATE to the PART-y (2019) (38)
Whole-body tremulousness: isolated generalized polymyoclonus. (2007) (38)
Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech (2018) (38)
Modeling trajectories of regional volume loss in progressive supranuclear palsy (2013) (37)
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. (2009) (37)
Cognitive impairment in progressive supranuclear palsy is associated with tau burden (2017) (36)
Voxel-based morphometry and its application to movement disorders. (2007) (36)
Neuropsychiatric Symptoms in Primary Progressive Aphasia and Apraxia of Speech (2015) (36)
Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia (2018) (36)
Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants (2019) (35)
Primary Progressive Aphasias and Apraxia of Speech (2019) (35)
Rates of cerebral atrophy in autopsy‐confirmed progressive supranuclear palsy (2006) (34)
The pimple sign of progressive supranuclear palsy syndrome. (2014) (34)
A 54-year-old man with slowness of movement and confusion (2007) (34)
Parkinsonism and dropped head: dystonia, myopathy or both? (2012) (33)
Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia. (2007) (33)
Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. (2013) (33)
Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy. (2011) (32)
The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose F18 positron emission tomography. (2010) (32)
Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia (2013) (31)
Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome (2019) (31)
Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia. (2012) (30)
Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration. (2019) (30)
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
Heterozygous Niemann-Pick disease type C presenting with tremor (2004) (30)
Diffuse Lewy body disease manifesting as corticobasal syndrome (2018) (29)
Neuronal intranuclear inclusion disease is genetically heterogeneous (2020) (29)
APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia (2014) (29)
Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy. (2020) (29)
Primary progressive apraxia of speech: from recognition to diagnosis and care (2020) (29)
Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease. (2020) (29)
The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease (2019) (28)
FRONTOTEMPORAL LOBAR DEGENERATION WITH UPPER MOTOR NEURON DISEASE/ PRIMARY LATERAL SCLEROSIS (2007) (28)
Dominant Frontotemporal Dementia Mutations in 140 Cases of Primary Progressive Aphasia and Speech Apraxia (2015) (28)
Disrupted functional connectivity in primary progressive apraxia of speech (2018) (28)
The clinical spectrum of stereotypies in frontotemporal lobar degeneration (2009) (28)
Very early semantic dementia with progressive temporal lobe atrophy: an 8-year longitudinal study. (2008) (28)
MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy (2018) (28)
Extending the clinicopathological spectrum of neurofilament inclusion disease (2005) (28)
A Neuropsychiatric Analysis of the Cotard Delusion. (2017) (27)
Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome. (2019) (27)
Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers (2019) (27)
Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study. (2015) (26)
Young-Onset Dementia: A Practical Approach to Diagnosis (2006) (26)
Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. (2005) (25)
Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. (2008) (25)
Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia (2019) (25)
Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia (2013) (25)
Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy (2013) (24)
Deep brain stimulation in benign tremulous parkinsonism. (2011) (24)
Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy. (2018) (24)
Progranulin gene mutation with an unusual clinical and neuropathologic presentation (2008) (24)
Ifosfamide associated myoclonus-encephalopathy syndrome (2011) (24)
Cognitive and Noncognitive Neurological Features of Young-Onset Dementia (2009) (23)
Alpha-synuclein studies are negative in postencephalic parkinsonism of von Economo. (2002) (23)
The relationship between histopathological features of progressive supranuclear palsy and disease duration. (2006) (22)
Frontotemporal lobar degeneration. (2007) (22)
GCH1 in early‐onset Parkinson's disease (2009) (22)
Rapidly Progressive Young-Onset Dementia (2009) (22)
Sensitivity–Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration (2020) (22)
Dopamine agonists and Othello's syndrome. (2010) (21)
Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration (2018) (21)
An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant (2019) (21)
Alpha‐synuclein immunohistochemistry in two cases of co‐occurring idiopathic Parkinson's disease and motor neuron disease (2005) (21)
Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid (2012) (21)
Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity. (2016) (21)
Clinical Features and Survival of 3R and 4R Tauopathies Presenting as Behavioral Variant Frontotemporal Dementia (2007) (21)
Voxel-Based Morphometry in Tau-Positive and Tau-Negative Frontotemporal Lobar Degenerations (2004) (21)
Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants (2018) (20)
Dysphagia in Progressive Supranuclear Palsy (2019) (20)
TDP-43 in Alzheimer’s disease is not associated with clinical FTLD or Parkinsonism (2014) (20)
Tracking the development of agrammatic aphasia: A tensor-based morphometry study (2017) (19)
The clinical spectrum and natural history of pure akinesia with gait freezing (2016) (19)
Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy. (2016) (19)
Ideomotor apraxia in agrammatic and logopenic variants of primary progressive aphasia (2013) (19)
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech (2021) (19)
Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia. (2016) (19)
Right temporal variant frontotemporal dementia with motor neuron disease (2012) (19)
TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia. (2018) (19)
Sporadic corticobasal syndrome with progranulin mutation presenting as progressive apraxic agraphia. (2011) (19)
Clinicopathologic discrepancies in a population‐based incidence study of parkinsonism in olmsted county: 1991‐2010 (2017) (18)
Imaging measures predict progression in progressive supranuclear palsy (2012) (18)
Patterns of Neuropsychological Dysfunction and Cortical Volume Changes in Logopenic Aphasia. (2018) (18)
18F‐AV‐1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy (2019) (18)
The diagnosis of progressive supranuclear palsy: current opinions and challenges (2018) (17)
Current and future management of the corticobasal syndrome and corticobasal degeneration. (2008) (17)
Clinical Progression in Four Cases of Primary Progressive Apraxia of Speech. (2018) (17)
Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type. (2015) (17)
Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech (2017) (17)
Primary progressive aphasia and transient global amnesia. (2012) (17)
Coprophagia in neurologic disorders (2016) (17)
Key emerging issues in progressive supranuclear palsy and corticobasal degeneration (2015) (16)
Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy (2020) (16)
Patterns of brain atrophy in frontotemporal dementia with mutations in MAPT or PGRN (2009) (16)
Western Aphasia Battery–Revised Profiles in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech (2019) (15)
Phonologic errors in the logopenic variant of primary progressive aphasia (2014) (15)
Microbleeds in the logopenic variant of primary progressive aphasia (2014) (15)
Enlarging vertebrobasilar dolichoectasia with subarachnoid hemorrhage heralded by recurrent ischemia. Case illustration. (2000) (15)
Multimodal neuroimaging relationships in progressive supranuclear palsy. (2019) (15)
Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa (2019) (15)
The Alien Limb (2004) (15)
MRI correlates of alien leg‐like phenomenon in corticobasal degeneration (2005) (14)
Pick’s disease: clinicopathologic characterization of 21 cases (2020) (14)
Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS (2013) (14)
Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: A case series (2012) (13)
MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous (2020) (13)
Single-cell profiling of the human primary motor cortex in ALS and FTLD (2021) (13)
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype (2020) (13)
Tau uptake in agrammatic primary progressive aphasia with and without apraxia of speech (2018) (13)
The alien limb phenomenon and Creutzfeldt-Jakob disease. (2012) (13)
FTDP‐17 with Pick body‐like inclusions associated with a novel tau mutation, p.E372G (2017) (13)
Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation (2021) (13)
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy (2019) (13)
Quantitative Analysis of Agrammatism in Agrammatic Primary Progressive Aphasia and Dominant Apraxia of Speech. (2018) (12)
Psychoses as the presenting manifestation of Creutzfeldt-Jakob disease in an elderly male. (2011) (12)
Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension (2019) (12)
Transient Epileptic Amnesia: A Treatable Cause of Spells Associated With Persistent Cognitive Symptoms (2019) (12)
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. (2020) (12)
Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers (2017) (12)
Varied electrophysiologic patterns in spinocerebellar ataxia type 2 (2006) (12)
Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases (2021) (11)
Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia (2016) (11)
Pallidonigroluysian atrophy associated with p.A152T variant in MAPT. (2013) (11)
Neuroanatomical correlates of phonologic errors in logopenic progressive aphasia (2020) (11)
C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation (2019) (11)
Effect Modifiers of TDP-43 Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes. (2020) (11)
Effect of MAPT and APOE on prognosis of progressive supranuclear palsy (2006) (11)
Submentalis Rapid Eye Movement Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy (2019) (10)
Prominent auditory deficits in primary progressive aphasia: A case study (2019) (10)
Sample size calculations for clinical trials targeting tauopathies: a new potential disease target (2015) (10)
Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease. (2020) (10)
Unlocking the mysteries of TDP-43 (2015) (10)
Primary lateral sclerosis as progressive supranuclear palsy: Diagnosis by diffusion tensor imaging (2012) (10)
Focal brain atrophy in gastric bypass patients with cognitive complaints (2011) (10)
Corticobasal Ganglionic Degeneration (2010) (10)
Rest in peace FTDP-17. (2018) (9)
Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer’s disease: a case-control study (2020) (9)
Patterns of brain atrophy in frontotemporal dementia with mutations in MAPT or PGRN (2009) (9)
Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech (2016) (9)
Aphasia with left occipitotemporal hypometabolism: A novel presentation of posterior cortical atrophy? (2013) (9)
Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice (2019) (9)
FUS pathology deﬁnes the majority of tau- and TDP-43-negative frontotemporal lobar degeneration (2010) (8)
TDP-43 is not present in brain tissue of patients with schizophrenia (2009) (8)
Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes (2020) (8)
Diffusion tensor imaging analysis in three progressive supranuclear palsy variants (2021) (8)
Neuroimaging Correlates of Pathologically-Defined Atypical Alzheimer's Disease (P05.049) (2012) (8)
Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha‐Synucleinopathies (2020) (8)
Incidence of frontotemporal disorders in Olmsted County: A population-based study (2019) (8)
Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
TDP‐43 in the olfactory bulb in Alzheimer's disease (2016) (8)
The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia (2019) (7)
Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy (2021) (7)
Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease (2021) (7)
Occupational Differences Between Alzheimer’s and Aphasic Dementias (2013) (7)
Neurofilament inclusion body disease (2003) (7)
Neuropathology and emerging biomarkers in corticobasal syndrome (2022) (7)
Neurodegenerative Diseases: Alzheimer's disease: overview (2005) (7)
Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion (2013) (7)
Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET (2021) (6)
Cerebrovascular pathology and misdiagnosis of multiple system atrophy: An autopsy study. (2020) (6)
Survival Analysis in Primary Progressive Apraxia of Speech and Agrammatic Aphasia. (2020) (6)
Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration. (2020) (6)
Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech (2020) (6)
Communication Limitations in Patients With Progressive Apraxia of Speech and Aphasia. (2020) (6)
Neuronal intranuclear inclusion disease (2011) (6)
Can Clinical Features Predict Tau Pathology in Patients with Behavioral Variant Frontotemporal Dementia (bvFTD)? (P05.101) (2013) (6)
Old age genetically confirmed frontotemporal lobar degeneration with TDP‐43 has limbic predominant TDP‐43 deposition (2021) (6)
December 14, 2009Plenary Session December 14Not your father's Parkinson's disease: non-motor symptoms of PD8:00–10:00 Hall IO.014 Neuropathology of non-motor features of Parkinson disease (2009) (6)
Quantitative assessment of grammar in amyloid-negative logopenic aphasia (2018) (6)
Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study. (2020) (6)
Guillain-Barré syndrome in an immunocompromised patient and coccidioidomycosis infection. (2006) (6)
Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsy. (2020) (6)
Characterization of frontotemporal dementia +/- amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (5)
Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging‐pathology study (2020) (5)
Relationship Between 18F-Flortaucipir Uptake and Histologic Lesion Types in 4-Repeat Tauopathies (2021) (5)
Dementia with Lewy bodies presenting as Logopenic variant primary progressive Aphasia (2020) (5)
Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy (2021) (5)
TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease (2020) (5)
Dementia and the TAR DNA Binding Protein 43 (2010) (5)
Uptake of AV-1451 in meningiomas (2017) (4)
Rapid rate on quasi-speech tasks in the semantic variant of primary progressive aphasia: A non-motor phenomenon? (2018) (4)
Depression and Apathy across Different Variants of Progressive Supranuclear Palsy (2021) (4)
TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death (2021) (4)
Non-right handed primary progressive apraxia of speech (2018) (4)
Diffuse Lewy body disease presenting as Parkinson's disease with progressive aphasia (2022) (4)
Autopsy Validation of Progressive Supranuclear Palsy‐Predominant Speech/Language Disorder Criteria (2021) (4)
Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech (2019) (4)
Measurement of grey matter water diffusion in the clinical variants of frontotemporal lobar degeneration and Alzheimer's disease (2009) (4)
White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition (2022) (4)
Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years (2022) (4)
Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy. (2021) (4)
Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease (2022) (4)
Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years (2022) (4)
Electroencephalography in primary progressive aphasia and apraxia of speech (2018) (4)
Natural History of “Pure” Primary Lateral Sclerosis (2021) (4)
Clinical and pathologic features of cognitive-predominant corticobasal degeneration (2020) (4)
Successful Treatment of Status Migrainosus After Electroconvulsive Therapy With Dihydroergotamine (2005) (4)
PSP-like syndrome after aortic surgery in adults (Mokri syndrome). (2020) (3)
Tractography of supplementary motor area projections in progressive speech apraxia and aphasia (2022) (3)
TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration (2022) (3)
Revised clinical diagnostic criteria for progressive supranuclear palsy (PSP) (2016) (3)
Phonological Errors in Posterior Cortical Atrophy (2021) (3)
Neuropsychological Correlates of Parietal Atrophy in Logopenic Progressive Aphasia (P02.029) (2012) (3)
Rare Tauopathies (2019) (3)
Levodopa Responsiveness in Adult-onset Lower Limb Dystonia is Associated with the Development of Parkinson’s Disease (2013) (3)
APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease (2022) (3)
Underlying pathology identified after 20 years of disease course in two cases of slowly progressive frontotemporal dementia syndromes (2021) (3)
Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia (2022) (3)
Neurobehavioral Characteristics of FDG-PET Defined Right-Dominant Semantic Dementia: A Longitudinal Study (2021) (3)
Corrigendum to "Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies" [Parkinsonism Relat Disord 17 (2011) 260-264] (2011) (3)
Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy (2021) (3)
Tauopathies: Classification, Clinical Features, and Genetics (2015) (3)
In Vivo Imaging and Autoradiography in a Case of Autopsy-Confirmed Pick Disease. (2019) (3)
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations (2021) (3)
Clinical aspects of TDP-43 proteinopathy, neurofilament inclusion body disease and dementias lacking distinctive proteinopathy. (2008) (3)
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease (2013) (3)
Neurodegeneration of the visual word form area in a patient with word form alexia (2021) (2)
P3-343 Progressive supranuclear palsy presenting as progressive nonfluent aphasia (2004) (2)
MRI in pathologically defined hippocampal sparing and limbic predominant atypical variants of Alzheimer's disease (2012) (2)
Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy (2021) (2)
Neuronal intermediate filament inclusion disease may be incorrectly classified as a subtype of FTLD-FUS. (2020) (2)
A Longitudinal Evaluation of Speech Rate in Primary Progressive Apraxia of Speech. (2021) (2)
Sleep disturbances in the speech-language variant of progressive supranuclear palsy. (2021) (2)
Limb immobilization and corticobasal syndrome. (2012) (2)
Differential diagnosis of neurodegenerative dementias using structural MRI (2009) (2)
Neurocognitive speed associates with frontotemporal lobar degeneration TDP-43 subtypes (2013) (2)
Progressive Supranuclear Palsy and Corticobasal Degeneration. (2021) (2)
Fitting TDP-43 into the APOE ε4 and neurodegeneration story (2018) (2)
Brain tau deposition linked to systemic causes of death in normal elderly (2017) (2)
MRI in pathologically-defined hippocampal sparing and limbic predominant atypical variants of Alzheimer's disease (2012) (2)
Progressive apraxia of speech: delays to diagnosis and rates of alternative diagnoses (2021) (2)
Clinical, Imaging, and Pathologic Characteristics of Patients With Right vs Left Hemisphere–Predominant Logopenic Progressive Aphasia (2021) (2)
Word Fluency Test Performance in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech. (2021) (2)
Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology (2022) (2)
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP (2022) (2)
Magnetic Resonance Imaging in Movement Disorders: Tauopathies (2013) (2)
Fluorodeoxyglucose F18 PET in progressive emotional dysprosody (2012) (2)
Symptom Prevalence of Neurodegenerative Diseases among Minorities (2017) (2)
Neuropsychological Pro fi les Differ among the Three Variants of Primary Progressive Aphasia (2015) (2)
Longitudinal flortaucipir ([18F]AV-1451) PET uptake in semantic dementia (2020) (2)
Pramipexole induced compulsive behaviors abate after initiation of rotigitine (2009) (1)
Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease (2021) (1)
Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant (2022) (1)
P4-118 MRI correlates of the language and behavioral variants of frontotemporal dementia when both are characterized by ubiquitin-only immunoreactive changes (2006) (1)
A Preliminary Report of Network Electroencephalographic Measures in Primary Progressive Apraxia of Speech and Aphasia (2022) (1)
Erratum: LATE to the PART-y (Brain (2019) 142 (e47) DOI: 10.1093/brain/awz224) (2019) (1)
Neuroanatomical Signature of C9ORF72: A Comparison to MAPT, Progranulin and Sporadic FTD (P05.061) (2012) (1)
REGIONAL BETA-AMYLOID PET COMPARISON ACROSS ATYPICAL AND TYPICAL VARIANTS OF ALZHEIMER’S DISEASE (2016) (1)
Molecular neuroimaging in primary progressive aphasia with predominant agraphia (2018) (1)
Asymmetric caudate hypometabolism in the absence of frontal involvement on FDG‐PET in patients with semantic dementia and behavioral symptoms (2020) (1)
A COMPARISON OF THE REGIONAL DISTRIBUTION OF MICROBLEEDS IN ATYPICAL AND TYPICAL PRESENTATIONS OF ALZHEIMER'S DISEASE (2014) (1)
TDP-43 AMPLIFIES MEMORY LOSS AND HIPPOCAMPAL ATROPHY IN ALZHEIMER'S DISEASE (2014) (1)
Frontal asymmetry in behavioral variant FTD: clinicoimaging & pathogenetic correlates (2012) (1)
Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia (2022) (1)
AV-1451 TAU-PET BINDING IN TYPICAL AND ATYPICAL SYNDROMIC VARIANTS OF ALZHEIMER’S DISEASE (2016) (1)
Primary Progressive Apraxia of Speech (PAS): A Distinct Neurodegenerative Syndrome (P07.167) (2012) (1)
THE INFLUENCE OF BETA-AMYLOID ON THE PROGRESSION OF PROGRESSIVE APRAXIA OF SPEECH (2018) (1)
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. (2022) (1)
TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease. (2022) (1)
Progressive Apraxia of Speech: Might There Be Subtypes? (2013) (1)
The Apraxia of Speech Rating Scale: Reliability, Validity, and Utility. (2023) (1)
Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study (2013) (1)
Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech (2023) (1)
Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old (2022) (1)
Progressive dysexecutive syndrome due to Alzheimer’s disease: A description of 55 cases and comparisons to other clinical AD phenotypes (2020) (1)
Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis? (2022) (1)
A 34-year-old man with progressive behavioral and language disturbance (2007) (1)
Frontotemporal dementia: a peek under its invisibility cloak (2015) (1)
Posterior cortical atrophy: Primary occipital variant (2022) (1)
A novel CSF1R variant in a South Dakota family with CSF1R-related leukoencephalopathy. (2022) (1)
Dynamic Aphasia as a Variant of Frontotemporal Dementia (2021) (1)
NEUROPATHOLOGIC FEATURES OF AV1451 TAU PET AUTORADIOGRAPHY IN DEMENTIA (2016) (1)
Atypical Alzheimer’s disease phenotypes with normal or borderline PET biomarker profiles (2022) (1)
Progressive Supranuclear Palsy (2015) (1)
A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 (2012) (1)
LONGITUDINAL MRI AND NEUROPSYCHOLOGICAL CHANGES IN SYMPTOMATIC FRONTOTEMPORAL LOBAR DEGENERATION SUBJECTS WITH MUTATIONS IN MAPT, PGRN, AND C9ORF72 (2014) (1)
Dual pathologies: Utility of TAR DNA‐binding Protein 43 (TDP‐43) Staining in Patients with Frontal and Temporal Lobe Abnormalities and Alzheimer disease (2007) (1)
Transthyretin as Potential Biomarker for C9ORF72-related Diseases (I8-2A) (2015) (1)
Tracking the Development of Aphasia in Primary Progressive Apraxia of Speech: A Tensor-Based Morphometry Study (P4.032) (2016) (1)
The Alien Limb Phenomenon & Creutzfeldt-Jakob Disease (P03.257) (2012) (1)
Rates of atrophy differ across pathologically defined subtypes of Alzheimer's disease: A longitudinal MRI study (2013) (1)
Parkinson disease and down in the dumps (2010) (1)
Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson Disease (1991-2010). (2022) (1)
Sensitivity of Consensus Criteria in the Quantitative Classification of Primary Progressive Aphasia (P6.233) (2014) (1)
Aphasia with left occipitotemporal hypometabolism: A novel presentation of posterior cortical atrophy? (2013) (1)
Globular Glial Tauopathy Presenting as Semantic Variant PPA (P6.226) (2016) (1)
Subject Index Vol. 17, 2004 (2004) (1)
Relationship of APOE, age, amyloid and clinical phenotype in Alzheimer disease (2021) (1)
P3.059 Glial activation in incidental Lewy body disease (2009) (1)
Impulse Control Disorders and Dopaminergic Drugs—Reply (2006) (1)
25-year-old woman with incoordination and decreased balance. (2001) (1)
Determinants of survival in autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC) (2011) (1)
P4-120 Demystifying the degenerative aphasias and apraxia of speech (2006) (0)
Cognitive Decline Is Only Part of the Story (2020) (0)
White matter health in the context of Alzheimer’s disease pathophysiology (2022) (0)
Microbleeds in logopenic progressive aphasia (2012) (0)
Contents Vol. 27, 2009 (2009) (0)
IC-P2-146: Antemortem MRI-based structural abnormality index (STAND): Scores correlate with postmortem Alzheimer disease Braak stages (2008) (0)
FDG-PET in Pathologically Confirmed 4R-Tauopathy Variants (P5.251) (2014) (0)
AV-1451 TAU-PET IN CLINICAL VARIANTS OF PROGRESSIVE SUPRANUCLEAR PALSY (2016) (0)
Tau Negative FTLD Without Abnormal TDP‐43 Immunoreactivity (2008) (0)
American Association of Neuropathologists, Inc. Abstracts of the 84th Annual Meeting: April 4-7, 2008 San Diego, California (2008) (0)
Seed-based characterization of intrinsic connectivity networks for distinguishing dementia (2011) (0)
Neurodegenerative Diseases: Mild cognitive impairment (2005) (0)
Diagnosis and management of dementia in Parkinson's disease (2004) (0)
Structural and functional connectivity in the logopenic variant of primary progressive aphasia and a comparison to dementia of the Alzheimer's type (2013) (0)
Characterization of Frontotemporal Dementia +/- Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72 (S54.005) (2012) (0)
P3-018: Alzheimer's disease presenting as corticobasal syndrome (2008) (0)
Spatial patterns of elevated magnetic susceptibility in progressive apraxia of speech (2023) (0)
“I Have Been Taking the Same Medications for Years” (2020) (0)
Refractory “VGKC Encephalopathy” (2020) (0)
A Pause in the Clause (2020) (0)
SUBJECT-LEVEL ASSESSMENT OF REGIONAL CORRELATIONS BETWEEN TAU-PET, AMYLOID-PET, MRI AND FDG-PET ACROSS THE CLINICAL SPECTRUM OF ALZHEIMER’S DISEASE (2017) (0)
Frequency of TAR DNA‐binding protein 43 (TDP‐43) increases linearly with age in the demented and non‐demented elderly population (2022) (0)
Daytime Polysomnography Recording in LIG1 -Related Limbic Encephalitis—Reply (2012) (0)
P3.015 Assessing non-cortical glucose metabolism in corticobasal syndrome (2009) (0)
Optimizing software methods for measuring flortaucipir SUVR change over time (2021) (0)
DIADEM / Participants Directory (2004) (0)
“I Have Snored All My Life and It Never Affected My Work” (2020) (0)
Network electroencephalographic (EEG) measures in primary progressive apraxia of speech and aphasia (2020) (0)
C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation (2019) (0)
Change in communication‐related participation in primary progressive apraxia of speech and aphasia (2021) (0)
P1-308: A voxel-based morphometry study correlating MRI with Braak neurofibrillary tangle stage at autopsy (2008) (0)
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
An autoradiographic evaluation of AV-1451 Tau PET in dementia (2016) (0)
ASSESSING THE SPECTRUM OF NON-LANGUAGE COGNITIVE DEFICITS IN LOGOPENIC APHASIA (2017) (0)
Stepwise functional brain architecture from disease epicenter correlates with atrophy in progressive supranuclear palsy (P11-6.001) (2023) (0)
SUBJECT-LEVEL ASSESSMENT OF REGIONAL CORRELATIONS BETWEEN TAU-PET, AMYLOID-PET, MRI AND FDG-PET ACROSS THE CLINICAL SPECTRUM OF ALZHEIMER’S DISEASE (2017) (0)
IC-03-07: A voxel-based morphometry study correlating MRI with Braak neurofibrillary tangle stage at autopsy (2008) (0)
1.012 Cardiac sympathetic denervation is early and progressive in Lewy body disease (2007) (0)
APOE ε4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia. (2023) (0)
Clinicopathologic phenotypes of four cases with MAPT P301L mutation (P2.164) (2015) (0)
Different anatomical subtypes of behavioral variant frontotemporal dementia identified using cluster analysis (2009) (0)
It’s Just Old Age (2020) (0)
A Case of Atypical Alzheimer’s Disease With Clinical Manifestation That Straddled the Boundary Between Primary Progressive Aphasia and Posterior Cortical Atrophy (2022) (0)
Differentiation of bvFTD and Alzheimer's disease Using Grey Matter DTI and Volume Measurements (2010) (0)
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal dementia and GRN mutations : a genome-wide association study (2018) (0)
Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies (2022) (0)
TDP-43 in Alzheimer’s Disease Is Not Associated with Parkinsonian Features or Clinical FTD (P4.206) (2014) (0)
Microbleeds in logopenic progressive aphasia (2012) (0)
CLINICAL AND NEUROIMAGING BIOMARKERS OF ALZHEIMER'S DISEASE PRESENTING WITH PROGRESSIVE APHASIA (2014) (0)
It’s Not Alzheimer Disease; Now What? (2020) (0)
Dual pathologies: utility of TAR DNA-binding protein 43 (TDP-43) staining in patients with frontal and temporal lobe abnormalities and Alzheimer disease: 41.3 (2007) (0)
IC-02-05 GENDER DIFFERENCES IN THE ASSOCIATION BETWEEN LONGITUDINAL BRAIN CHANGES AND BASELINE LEVELS OF CSFALZHEIMER’S DISEASE AND GLIAL BIOMARKERS IN HEALTHY ELDERS (2019) (0)
Differentiation of bvFTD and Alzheimer's disease using grey matter DTI and volume measurements (2010) (0)
P2-170 Patterns of atrophy on MRI in histologically-proven sporadic Alzheimer's disease and genetically-proven familial Alzheimer's disease (2004) (0)
Diagnostic yield of rem sleep muscle activity for presumed synucleinopathy neurodegeneration (2019) (0)
Corticobasal: The Syndrome versus the Pathology (2020) (0)
Contents Vol. 17, 2004 (2004) (0)
Common Pitfalls in Cognitive and Behavioral Neurology (2020) (0)
Frontotemporal lobar degeneration with upper motor neuron disease/primary lateral sclerosis (2007) (0)
Neurocognitive Phenotypes across Frontotemporal Lobar Degeneration TDP-43 Subtypes (P05.067) (2012) (0)
P3-173 Apolipoprotein E frequency in posterior cortical atrophy and typical Alzheimer’s disease (2006) (0)
Recognizing the Right Signs of Memory Impairment (2020) (0)
REPURPOSING FDG-PET AS A DIAGNOSTIC TOOL FOR ALZHEIMER’S-RELATED TDP-43-PROTEINOPATHY (2019) (0)
Subject Index Vol. 27, 2009 (2009) (0)
sCJD with Negative 14–3–3? (2020) (0)
Unique brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy (2022) (0)
Imaging brain atrophy in progressive supranuclear palsy and corticobasal syndromes: potential for diagnosis and monitoring of disease progression (2012) (0)
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP (2022) (0)
Primary progressive apraxia of speech: Clinico-pathological associations of left-right hemispheric dominance (S8.008) (2023) (0)
Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography (2022) (0)
Frontal, Parietal, or Neither? (2020) (0)
Biomarker Confirmed Alzheimer’s Disease Presenting as Amnestic, Aphasic, and Visual Variants: Hippocampal Volume Comparison (I12.009) (2016) (0)
Optimum differentiation of FTLD from AD achieved with cross‐sectional tau PET (2022) (0)
Functional Connectivity From Disease Epicenters in Frontotemporal Dementia. (2023) (0)
Corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy, argyrophilic grain disease, and rarer neurodegenerative diseases (2016) (0)
Neuropsychological Profiles of Patients with Progressive Apraxia of Speech and Aphasia (2021) (0)
HETEROGENEOUS PRESENTATIONS IN POSTERIOR CORTICAL ATROPHY (2018) (0)
LONGITUDINAL CHANGES IN BRAIN MRI AND NEUROPSYCHOMETRICS IN ASYMPTOMATIC AND SYMPTOMATIC FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION WITH MUTATIONS IN MAPT (2014) (0)
Remembering That We Forget versus Forgetting Altogether (2020) (0)
Frontotemporal dementia syndromes (2008) (0)
P4-161 The Lewy body variant of posterior cortical atrophy (2006) (0)
Assessing Patients and Care Partner Ratings of Communication-Related Participation Restrictions: Insights From Degenerative Disease. (2023) (0)
Rate Modulation Abilities in Acquired Motor Speech Disorders. (2023) (0)
A Retrospective Review of the Phenomenon of Gait Freezing (P1.075) (2016) (0)
The Disease Has Caught Up with Her (2020) (0)
Parkinsonism, Ataxia, and Cognitive Impairment after Radiation Therapy (2020) (0)
Young Onset Dementia (2013) (0)
P1-255: Neuropathological correlates of antemortem 1H MR spectroscopy in Alzheimer's disease (2008) (0)
IC-P-024 MRI, MRS and clinical correlates in posterior cortical atrophy and typical Alzheimer’s disease (2006) (0)
When both motion and mentation fail Hasmet A Hanagasi and Murat Emre (2008) (0)
Predicting Decline in Agrammatism, Apraxia of Speech and Parkinsonism in Agrammatic Primary Progressive Aphasia (P4.030) (2016) (0)
PRINCIPAL AXES OF PHENOTYPIC VARIABILITY IN ALZHEIMER’S DISEASE DERIVED FROM AN FDG-PET BASED UNSUPERVISED MACHINE LEARNING ALGORITHM (2018) (0)
Demographic and Etiologic Characteristics of 235 Patients (2016) (0)
Atypical and Vascular Parkinsonism in Jamaica (P06.078) (2012) (0)
Focal Cortical Degenerations (2015) (0)
ANTEMORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON-FTLD OLDER ADULTS (2019) (0)
Longitudinal clinical decline and baseline predictors in progressive supranuclear palsy. (2023) (0)
IC-P1-034: Neuropathological correlates of antemortem 1H MR spectroscopy in Alzheimer's disease (2008) (0)
assessment of frontal function and behavioral symptoms across subtypes of primary progressive aphasia, semantic dementia and progressive apraxia of speech : p302 (2016) (0)
Cognitive Endophenotype Associated with the C9ORF72 GGGGCC Expansion in FTD/ALS (P05.063) (2012) (0)
APOE ɛ4 Influences Within and Between Network Functional Connectivity in Atypical Alzheimer Disease (P11-6.006) (2023) (0)
Longitudinal beta-amyloid PET in atypical Alzheimer’s disease and frontotemporal lobar degeneration (2020) (0)
Patient and Care Partner Ratings of Communication Participation in Frontotemporal Dementia (2022) (0)
Characteristics, caregiver evaluations, and telephone call volume of a frontotemporal dementia caregiver educational and support program (2015) (0)
Cognitive Impairment as an Unexpected Guest (2020) (0)
Dementia Associated Epileptogenic Abnormalities: Implications for Testing, Treatment and Prognosis (P04.224) (2012) (0)
Assessing Change in Communication Limitations in Primary Progressive Apraxia of Speech and Aphasia: A 1-Year Follow-Up Study. (2021) (0)
STRUCTURAL EQUATION MODELLING REVEALS A DIRECT AND INDIRECT EFFECT OF APOE ε4 ON TAR DNA BINDING PROTEIN 43 (2018) (0)
Posterior Cortical Atrophy: Primary Occipital Variant (2022) (0)
Author Response: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease (2022) (0)
0781 Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine (2005) (0)
TDP-43 IN ATYPICAL ALZHEIMER’S DISEASE DEMENTIA (2018) (0)
“I Keep Repeating Things to Him” (2020) (0)
Functional connectivity to the premotor cortex maps onto longitudinal brain neurodegeneration in progressive apraxia of speech (2022) (0)
Apraxia of Speech Rating Scale (2021) (0)
CLINICAL AND NEUROIMAGING BIOMARKERS OF ALZHEIMER'S DISEASE PRESENTING WITH PROGRESSIVE APHASIA (2014) (0)
I Don’t Know When to Stop (2020) (0)
Volumetric Analysis of Hippocampal Subregions and Subfields in Left and Right Predominant Semantic Dementia (P11-6.002) (2023) (0)
An Extended Analysis of the Histological Variants of Tau‐Negative FTLD (2008) (0)
Frontotemporal lobar degeneration with upper motor neuron disease/primary lateral sclerosis: 41.2 (2007) (0)
PREDICTING AMYLOID DEPOSITION IN PROGRESSIVE APHASIA AND APRAXIA OF SPEECH USING CLINICAL AND MRI DATA (2016) (0)
Clinico-radiologic and Pathological Evaluation of Corticobasal Syndrome (S8.004) (2023) (0)
Altered functional connectivity networks in logopenic progressive aphasia and posterior cortical atrophy (2022) (0)
REGIONAL TAU-PET UPTAKE PATTERNS AND THEIR ASSOCIATION WITH BRAAK STAGING, COGNITION, AND ONSET OF AD-DEMENTIA (2016) (0)
Herpes Encephalitis Recurrence? (2020) (0)
P2-348 MRI, MRS and clinical correlates in posterior cortical atrophy and typical Alzheimer’s disease (2006) (0)
Contents Vol. 39, 2015 (2015) (0)
Talking about Family Matters (2020) (0)
O4-06-02 The relationship between specific histopathology and patterns of atrophy on MRI in frontotemporal lobar degeneration (2004) (0)
The many faces of globular glial tauopathy: A clinical and imaging study (2022) (0)
IC-P2-154: Patterns of regional change over time in the syndromic variants of frontotemporal dementia and Alzheimer's disease (2008) (0)
Corrigendum to “Prosodic and phonetic subtypes of primary progressive apraxia of speech” [Brain Lang. 184 (2018) 54–65] (2020) (0)
Impulse control disorders and dopaminergic drugs. Authors' replay (2006) (0)
Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene (2014) (0)
Look below the Surface (EEG) (2020) (0)
“The Thing about Remembering Names of Things” (2020) (0)
REGION-LEVEL RELATIONSHIPS BETWEEN TAU, AMYLOID, HYPOMETABOLISM AND ATROPHY IN ATYPICAL ALZHEIMER’S DISEASE (2018) (0)
TAR DNA‐binding protein 43 (TDP‐43) contributes to the mismatch between medial temporal volumes and flortaucipir uptake in elderly patients with Alzheimer’s disease neuropathologic changes (2022) (0)
The Role of Diffusion Tensor Imaging To Uncover Primary Lateral Sclerosis Masquerading as Progressive Supranuclear Palsy (P03.118) (2012) (0)
Cross-Sectional and Longitudinal Assessment of Behavior in Primary Progressive Apraxia of Speech and Agrammatic Aphasia (2022) (0)
IC-P-144 PRINCIPAL AXES OF PHENOTYPIC VARIABILITY IN ALZHEIMER’S DISEASE DERIVED FROM AN FDG-PET BASED, UNSUPERVISED MACHINE LEARNING ALGORITHM (2018) (0)
Clinical Phenotypes of Primary Lateral Sclerosis with Minor Electromyographic Abnormalities (P4.462) (2018) (0)
Something Does Not Look Right (2020) (0)
Visuospatial impairment in logopenic progressive aphasia: Why do we not “see” it? (2021) (0)
Curious case of FTD-ALS (2020) (0)
THE INFLUENCE OF AGE ON REGIONAL [18F]AV-1451 PET, PITTSBURGH COMPOUND B PET AND MRI ATROPHY IN ATYPICAL ALZHEIMER’S DISEASE (2018) (0)
Antiphospholipid syndrome mimicking posterior cortical atrophy and the “railroad track” sign on brain fluorodeoxyglucose-positron emission tomography (2023) (0)
CLINICAL FEATURES, CSF BIOMARKERS, MOLECULAR IMAGING, AND PATHOLOGY IN DYSEXECUTIVE ALZHEIMER’S DISEASE (2018) (0)
Progressive Apraxia of Speech and Primary Progressive Aphasias (2014) (0)
Thursday, March 15, 2007. pp. 9–58 (2007) (0)
Atypical Parkinsonian Syndromes (2015) (0)
Parkinsonism in the Agrammatic and Logopenic Variants of Primary Progressive Aphasia (P02.047) (2012) (0)
DIAGNOSTIC UTILITY OF [18F]AV-1451 PET, FDG-PET AND MRI TO DIFFERENTIATE THE THREE VARIANTS OF PRIMARY PROGRESSIVE APHASIA (2018) (0)
Temporal Cortical Thickness and Cognitive Associations among Typical and Atypical Phenotypes of Alzheimer’s Disease (2022) (0)
Explorer Criteria for the diagnosis of corticobasal degeneration (2015) (0)
O3-06-06: Patterns of regional change over time in the syndromic variants of frontotemporal dementia and Alzheimer's disease (2008) (0)
Clinical Phenotypes of Pure Primary Lateral Sclerosis (S31.002) (2018) (0)
Neuropsychological Pro ﬁ les Differ among the Three Variants of Primary Progressive Aphasia (2015) (0)
Difficulty with Language: When Is It Not Aphasia? (2020) (0)
Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers (2019) (0)
A Cognitive Psychometric Investigation of Word Production and Phonological Error Rates in Logopenic Progressive Aphasia. (2021) (0)
A COMPARISON OF THE REGIONAL DISTRIBUTION OF MICROBLEEDS IN ATYPICAL AND TYPICAL PRESENTATIONS OF ALZHEIMER'S DISEASE (2014) (0)
Clinical aspects of dementia (2014) (0)
Quantitative TDP‐43 burden and distribution in old age: High and low probability of Alzheimer’s disease and genetically confirmed FTLD‐TDP‐43 (2021) (0)
Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (0)
“Memory Is So Good She Will Never Get Dementia” (2020) (0)
Clinical-pathological discrepancies in a population based incidence cohort study on parkinsonism in Olmsted County, MN: 1991–2005 (S22.008) (2017) (0)
STRUCTURAL EQUATION MODELLING REVEALS A DIRECT AND INDIRECT EFFECTOFAPOE ε 4ONTARDNABINDING PROTEIN 43 (2018) (0)
Dramatic improvement with donepezil in a case of dementia with Lewy bodies (2013) (0)
ANTE-MORTEM VOLUME LOSS MIRRORS TDP43 STAGING IN NON-FTLD OLDER ADULTS (2019) (0)
You Have Been Diagnosed with Alzheimer Disease; Is That It? (2020) (0)
O1-02-03: Antemortem MRI–based structural abnormality index (STAND) scores correlate with postmortem Alzheimer disease Braak stages (2008) (0)
TDP-43 DRIVES FASTER RATES OF HIPPOCAMPAL ATROPHY IN ALZHEIMER’S DISEASE STARTING AT LEAST 10 YEARS PRIOR TO DEATH (2017) (0)
A Kindred with Familial Frontotemporal Dementia and/or Amyotrophic Lateral Sclerosis Associated with the GGGGCC Repeat Expansion in C9ORF72 (P05.058) (2012) (0)
“That Is Not How I Feel” (2020) (0)
The novel p.K317N mutation in MAPT gene with clinicopathological phenotype of globular glial tauopathy (P2.161) (2015) (0)
An examination of atypical primary progressive aphasia variants (2021) (0)
IC-P-082 TAU AND ALPHA-SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIATHERAPEUTIC’S PM-PBB3 BINDING-SITE FOCUSED COMPOUND COLLECTION (2018) (0)
Distinct brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy (2022) (0)
LONGITUDINAL BEHAVIOR OF BETA-AMYLOID IN NEURODEGENERATIVE DEMENTIAS (2019) (0)
ADVANTAGES OF HIERARCHICAL MODELS FOR REGIONAL PET ANALYSES (2018) (0)
Seed-based characterization of intrinsic connectivity networks for distinguishing dementia (2011) (0)
Frontotemporal dementia in older adults: Diagnostic and therapeutic challenges (2009) (0)
P2-193: Patterns of cerebral perfusion in three clinical behavioral variants of frontotemporal dementia (2008) (0)
TDP‐43 Neuronal Cytoplasmic Inclusions in the Amygdala of Patients with Advanced Alzheimer Disease (2008) (0)
Erratum: Differentiating clinicopathologic and genetic aspects of hippocampal sclerosis in Alzheimer's disease from limbic predominant Alzheimer's disease and "pure" hippocampal sclerosis, (Alzheimer's and Dementia) (2012) (0)
The Stroke of Clarity (2020) (0)
Altered functional connectivity networks in logopenic progressive aphasia and posterior cortical atrophy (2022) (0)
REGIONAL BETA-AMYLOID PET COMPARISON ACROSS ATYPICAL AND TYPICAL VARIANTS OF ALZHEIMER’S DISEASE (2016) (0)
Decline in Visual and Posterior Cortical Functions in Logopenic Progressive Aphasia (P5-6.001) (2023) (0)
Dynamic aphasia with emerging agrammatism, anomia, and aberrant frontal behaviors in a case of atypical parkinsonism (2022) (0)
AV-1451 TAU-PET IN CLINICAL VARIANTS OF PROGRESSIVE SUPRANUCLEAR PALSY (2016) (0)
Does a Positive Amyloid Scan Always Mean Alzheimer Disease? (2020) (0)
2.321 Do chronic non-specific brain insults predispose to incidental Lewy Body Disease? An exploratory study (2007) (0)
Characterization of the Neuropsychiatric Features Associated with Mutations in C9ORF72' MAPT and PGRN (P05.065) (2012) (0)
“This Is Not Like Him” (2020) (0)
White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition (2022) (0)
IC-P1-011: Patterns of cerebral perfusion in 3 clinical behavioral variants of frontotemporal dementia (2008) (0)
Predicting Alzheimer Disease Versus Corticobasal Degeneration Pathology Underlying the Corticobasal Syndrome (P04.227) (2012) (0)
Characterizing amyloid positive individuals with normal tau PET levels five years later: An ADNI study (2021) (0)
Structural and functional connectivity in the logopenic variant of primary progressive aphasia and a comparison with dementia of the Alzheimer's type (2013) (0)
Pseudoatrophic Pattern in Hydrocephalus (2020) (0)
Unique brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy (2022) (0)
PRINCIPAL AXES OF PHENOTYPIC VARIABILITY IN ALZHEIMER’S DISEASE DERIVED FROM AN FDG-PET BASED, UNSUPERVISED MACHINE LEARNING ALGORITHM (2018) (0)
Typical, atypical and vascular parkinsonism in Jamaica: an 8-year prospective study (P7.288) (2015) (0)
P1.204 Combined resting–postural tremor – a variant of essential tremor (2009) (0)